Cargando…
A review of China’s compensation program for adverse reactions following immunization
Vaccination is a compelling measure to battle infectious diseases and protect public health. However, because of the constraints on human cognition, it is difficult to ensure that vaccines are safe. Adverse reactions to immunization can cause individual injury. In numerous countries, no-fault progra...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440378/ https://www.ncbi.nlm.nih.gov/pubmed/37608980 http://dx.doi.org/10.3389/fpubh.2023.1211976 |
_version_ | 1785093137850433536 |
---|---|
author | Yingxiong, Wu |
author_facet | Yingxiong, Wu |
author_sort | Yingxiong, Wu |
collection | PubMed |
description | Vaccination is a compelling measure to battle infectious diseases and protect public health. However, because of the constraints on human cognition, it is difficult to ensure that vaccines are safe. Adverse reactions to immunization can cause individual injury. In numerous countries, no-fault programs have been established to compensate individuals for vaccine-related injuries. China also established a vaccine injury compensation system with its own unique characteristics. The Vaccine Administration Law was promulgated in 2019 to establish a compensation system for those who experience adverse reactions following immunization; nevertheless, the compensation system is imperfect. Even when the applicable terms are applied to deal with vaccine-related injuries, some issues remain, such as unreasonable diagnosis and evaluation procedures for adverse reactions, excessively strict standards regarding proof and inconsistent compensation standards across the country. Therefore, to provide effective compensation for vaccine recipients, it is important to clarify the standards of proof and establish a sensible vaccine injury compensation system that includes Corona Virus Disease 2019 vaccine-injury compensation. |
format | Online Article Text |
id | pubmed-10440378 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104403782023-08-22 A review of China’s compensation program for adverse reactions following immunization Yingxiong, Wu Front Public Health Public Health Vaccination is a compelling measure to battle infectious diseases and protect public health. However, because of the constraints on human cognition, it is difficult to ensure that vaccines are safe. Adverse reactions to immunization can cause individual injury. In numerous countries, no-fault programs have been established to compensate individuals for vaccine-related injuries. China also established a vaccine injury compensation system with its own unique characteristics. The Vaccine Administration Law was promulgated in 2019 to establish a compensation system for those who experience adverse reactions following immunization; nevertheless, the compensation system is imperfect. Even when the applicable terms are applied to deal with vaccine-related injuries, some issues remain, such as unreasonable diagnosis and evaluation procedures for adverse reactions, excessively strict standards regarding proof and inconsistent compensation standards across the country. Therefore, to provide effective compensation for vaccine recipients, it is important to clarify the standards of proof and establish a sensible vaccine injury compensation system that includes Corona Virus Disease 2019 vaccine-injury compensation. Frontiers Media S.A. 2023-08-07 /pmc/articles/PMC10440378/ /pubmed/37608980 http://dx.doi.org/10.3389/fpubh.2023.1211976 Text en Copyright © 2023 Yingxiong. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Yingxiong, Wu A review of China’s compensation program for adverse reactions following immunization |
title | A review of China’s compensation program for adverse reactions following immunization |
title_full | A review of China’s compensation program for adverse reactions following immunization |
title_fullStr | A review of China’s compensation program for adverse reactions following immunization |
title_full_unstemmed | A review of China’s compensation program for adverse reactions following immunization |
title_short | A review of China’s compensation program for adverse reactions following immunization |
title_sort | review of china’s compensation program for adverse reactions following immunization |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440378/ https://www.ncbi.nlm.nih.gov/pubmed/37608980 http://dx.doi.org/10.3389/fpubh.2023.1211976 |
work_keys_str_mv | AT yingxiongwu areviewofchinascompensationprogramforadversereactionsfollowingimmunization AT yingxiongwu reviewofchinascompensationprogramforadversereactionsfollowingimmunization |